Answers are grounded in this paper and cite their sources.
Clinical trial reveals an inverse link between drug-induced tremor and symptom relief in schizophrenia, challenging traditional neuroleptic hypotheses.
A therapeutic trial with chlorpromazine was conducted with a homogeneous (for age and sex) group of recently admitted schizophrenic patients. Extrapyramidal effects were measured through quantitative analysis of digital tremor, after four days of fixed-dose treatment. Assessment of treatment efficacy was based on Brief Psychiatric Rating Scale ratings, done at the end of four weeks' treatment. Those patients whose tremor was least affected by drug were most likely to benefit from the treatment. Implications of this negative correlation for our understanding of the neuroleptic hypothesis and the closely associated dopamine hypothesis of schizophrenia are discussed.
No takes yet. Share an insight, caveat, or question.
Alpert et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: